IRCT2013120214333N13已完成未知
comparsion of the Effects of an anti-diabetic oligosaccharide rich fraction extracted from Rosa arvensis with common treatment on diabetic patients type2( a pilot study)
Barekat Pharmaceutical Company0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 year 至 65 years（—）
- 性别
- All
入选标准
- •diabetes diagnosis with fasting blood sugar over 125, or postprandial glucose over 200 or glycosylated hemoglobin level greater than 6; patient willingness and signed informed consent, age less than 65 years; history of diabetes less than 10 years; diabetes onset at least three months before.
- •Exclusion criteria: requiring insulin injections or diagnosis of type 1 diabetes, kidney disease, liver disease, cancer, anemia and heart failure, pregnancy, glycosylated hemoglobin over 10, corticosteroids use.
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
Comparison of efficacy of metformin plus dapagliflozin versus metformin plus insulin sensitizer in patients having diabetes mellitus type-2 in Pakistan.ACTRN12622000243718Dr. Malik Hassan Mehmood84
尚未招募
不适用
Comparative efficacy and safety of antidiabetic drugs in treating diabetes mellitusType 2 DiabetesJPRN-UMIN000032496The University of Tokyo10,000
招募中
3 期
Anti-diabetic Herbal DrugDiabetes type2.oral antidiabetic drugsZ79.84IRCT20170809035599N2Ahvaz University of Medical Sciences140
已完成
不适用
Investigation the possible anti-diabetic effect of water-solubule dietary fiber in human.Diabetes MellitusJPRN-UMIN000000805Kyoto Prefectural University of Medicine14
尚未招募
3 期
Management of pre-diabetic patients with ayurvedic medicatioCTRI/2023/11/059445Dr Minal Suresh Tadke